Skip to content

Clinical trials

Phase 1 Vulvar Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vulvar Neoplasms Phase: Phase 1 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20042
20061
20091
20121
20183
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
M.D. Anderson Cancer Center2
Regeneron Pharmaceuticals2
Abramson Cancer Center at Penn Medicine1
Alliance for Clinical Trials in Oncology1
Case Comprehensive Cancer Center1
Dana-Farber Cancer Institute1
NYU Langone Health1
National Institutes of Health Clinical Center (CC)1
Steven Waggoner, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vulvar Neoplasms17
Uterine Cervical Neoplasms16
Vaginal Neoplasms14
Endometrial Neoplasms12
Carcinoma, Ovarian Epithelial10
Fallopian Tube Neoplasms10
Anus Neoplasms8
Carcinoma, Hepatocellular8
Prostatic Neoplasms8
Neoplasms7

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.